hp518
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 14, 2021 (NCT05252364)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Androgen ReceptorDEGRADER
androgen receptor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06155084 | Phase 1 | Dec 31, 2023 | Hinova Pharmaceuticals, Inc. |
| NCT05252364 | Phase 1 | Dec 14, 2021 | Hinova Pharmaceuticals Aus Pty Ltd, Hinova Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hinova Pharmaceuticals, Inc. | For profit | 2 | 1 | 1 | 2021 |
| Hinova Pharmaceuticals Aus Pty Ltd | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1